[144] Broadcom Inc. SEC Filing
Rhea-AI Filing Summary
Broadcom Inc. (AVGO) Form 144 notice reports a proposed sale of 16,558 restricted common shares valued at approximately $5,755,740, to be executed through Charles Schwab & Co., Inc. on 09/17/2025 on NASDAQ.
The shares were acquired on 09/16/2025 through a restricted stock lapse from Broadcom as equity compensation and the planned sale is to be paid as equity compensation. The filing also discloses prior sales by the same person within the past three months totaling 110,646 shares with aggregate gross proceeds of $29,001,951.00 across transactions on 06/23/2025, 06/24/2025 and 09/16/2025.
The filer certifies they are not aware of any undisclosed material adverse information about the issuer.
Positive
- Clear disclosure of the proposed sale, including broker, exchange, number of shares, and aggregate market value
- Origin of shares identified as a restricted stock lapse from Broadcom, and payment type noted as equity compensation
- Prior recent sales reported, providing transparency on insider liquidity over the past three months
Negative
- No explicit trading plan date (Rule 10b5-1) is indicated in the remarks to show pre-commitment for the sales
- Insider selling volume is substantial in the past three months (110,646 shares, ~$29.0M), which may attract investor attention
Insights
TL;DR: Insider equity compensation converted and planned sale disclosed; sales volume appears routine but notable in size.
The filing shows a routine post-vesting sale under Rule 144: 16,558 shares valued at about $5.8 million are scheduled for 09/17/2025 through a broker, following a restricted stock lapse dated 09/16/2025. The filer also reported three earlier sell transactions totaling 110,646 shares and roughly $29.0 million in gross proceeds during the past three months. From an investor-impact perspective, this is a transparent disclosure of insider liquidity rather than new operational or financial information about Broadcom. The magnitude of recent sales is material only relative to the individual holder, not indicative here of company fundamentals.
TL;DR: Compliance with Rule 144 and representations are present; the filing documents insider selling post-vesting.
The notice documents that the shares originated from a restricted stock lapse and will be sold via an established brokerage on NASDAQ, consistent with standard insider compliance. The signer affirms no undisclosed material adverse information exists. There is no indication of a trading plan adoption date or Rule 10b5-1 instruction in the remarks, which would have clarified pre-commitment to sales. Overall, disclosure meets Rule 144 requirements but lacks an explicit trading-plan reference.